Jane Street’s Akari Therapeutics AKTX Stock Holding History

Jane Street’s Portfolio AKTX Stock Details AKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$158K	Buy	+15,463	New	+$133K	﹤0.01%	10303
2026 Q1	–	Sell	-1,791	Closed	-$20.7K	–	11458
2025 Q4	$20.7K	Buy	+1,791	New	+$41.6K	﹤0.01%	10717

Other funds holding AKTX

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Truvestments Capital Sarasota, Florida $673M AUM 55.24% 1-Year Est. Return

Jane Street's AKTX Position: Q2 2026 in Review

Jane Street opened a new position in Akari Therapeutics (AKTX) in Q2 2026: 15,463 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #10303 among its holdings. This is a return to the name: Jane Street previously reported a position in AKTX as recently as Q4 2025.

Jane Street first reported a position in AKTX in Q4 2025 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold AKTX as of Q2 2026.

Jane Street held 15,463 shares of Akari Therapeutics worth $158K as of Q2 2026.
Akari Therapeutics was a new Jane Street position in Q2 2026.
Akari Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10303 holding.
Jane Street first reported a position in Akari Therapeutics in Q4 2025 and has held it in 2 quarters since.
9 funds tracked by Wall St. Rank held Akari Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.